 | • レポートコード：GIR201113828 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール • 産業分類：機械・機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、細胞治療処理の世界市場を調査対象にし、細胞治療処理の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（製品、サービス、ソフトウェア）、用途別分析（心血管疾患、骨修復、神経疾患、骨格筋修復免疫疾患）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Anthrogenesis Corp.、Bluebird Bio Inc.、Epic Sciences、BioNTech、IBC Pharmaceuticals Inc.、Cell Ideas、Immunomedics Inc.、FuGENE、Roche、Immodulon-Therapeutics、Novartis、BioMed Valley Discoveries Inc.、Juno Therapeutics Inc.、UCL Business PLC.、Persimmune Inc.、Neurotech USA、Medlmmune Inc.、Regeneron Pharmaceuticals Inc.、Pluristem Therapeutics、NeoStem Oncology ・企業別売上、市場シェア ・細胞治療処理の地域別市場分析 ・細胞治療処理の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・細胞治療処理のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・細胞治療処理のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・細胞治療処理の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・細胞治療処理の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・細胞治療処理の種類別市場規模2015-2020：製品、サービス、ソフトウェア ・細胞治療処理の用途別市場規模2015-2020：心血管疾患、骨修復、神経疾患、骨格筋修復免疫疾患 ・細胞治療処理の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Cell therapy Processing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cell therapy Processing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cell therapy Processing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cell therapy Processing market has been segmented into:
Products
Services
Software
By Application, Cell therapy Processing has been segmented into:
Cardiovascular Disease
Bone Repair
Neurological Disorders
Skeletal Muscle RepairImmune Diseases
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cell therapy Processing market presented in the report. This section sheds light on the sales growth of different regional and country-level Cell therapy Processing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cell therapy Processing market.
The report offers in-depth assessment of the growth and other aspects of the Cell therapy Processing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cell therapy Processing Market Share Analysis
Cell therapy Processing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cell therapy Processing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cell therapy Processing sales, revenue and market share for each player covered in this report.
The major players covered in Cell therapy Processing are:
Anthrogenesis Corp.
Bluebird Bio Inc.
Epic Sciences
BioNTech
IBC Pharmaceuticals Inc.
Cell Ideas
Immunomedics Inc.
FuGENE
Roche
Immodulon-Therapeutics
Novartis
BioMed Valley Discoveries Inc.
Juno Therapeutics Inc.
UCL Business PLC.
Persimmune Inc.
Neurotech USA
Medlmmune Inc.
Regeneron Pharmaceuticals Inc.
Pluristem Therapeutics
NeoStem Oncology
1 Cell therapy Processing Market Overview
1.1 Product Overview and Scope of Cell therapy Processing
1.2 Classification of Cell therapy Processing by Type
1.2.1 Global Cell therapy Processing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cell therapy Processing Revenue Market Share by Type in 2019
1.2.3 Products
1.2.4 Services
1.2.5 Software
1.3 Global Cell therapy Processing Market by Application
1.3.1 Overview: Global Cell therapy Processing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cardiovascular Disease
1.3.3 Bone Repair
1.3.4 Neurological Disorders
1.3.5 Skeletal Muscle RepairImmune Diseases
1.4 Global Cell therapy Processing Market by Regions
1.4.1 Global Cell therapy Processing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cell therapy Processing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cell therapy Processing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cell therapy Processing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell therapy Processing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cell therapy Processing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell therapy Processing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Anthrogenesis Corp.
2.1.1 Anthrogenesis Corp. Details
2.1.2 Anthrogenesis Corp. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Anthrogenesis Corp. SWOT Analysis
2.1.4 Anthrogenesis Corp. Product and Services
2.1.5 Anthrogenesis Corp. Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bluebird Bio Inc.
2.2.1 Bluebird Bio Inc. Details
2.2.2 Bluebird Bio Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bluebird Bio Inc. SWOT Analysis
2.2.4 Bluebird Bio Inc. Product and Services
2.2.5 Bluebird Bio Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Epic Sciences
2.3.1 Epic Sciences Details
2.3.2 Epic Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Epic Sciences SWOT Analysis
2.3.4 Epic Sciences Product and Services
2.3.5 Epic Sciences Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioNTech SWOT Analysis
2.4.4 BioNTech Product and Services
2.4.5 BioNTech Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.5 IBC Pharmaceuticals Inc.
2.5.1 IBC Pharmaceuticals Inc. Details
2.5.2 IBC Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 IBC Pharmaceuticals Inc. SWOT Analysis
2.5.4 IBC Pharmaceuticals Inc. Product and Services
2.5.5 IBC Pharmaceuticals Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cell Ideas
2.6.1 Cell Ideas Details
2.6.2 Cell Ideas Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cell Ideas SWOT Analysis
2.6.4 Cell Ideas Product and Services
2.6.5 Cell Ideas Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Immunomedics Inc.
2.7.1 Immunomedics Inc. Details
2.7.2 Immunomedics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Immunomedics Inc. SWOT Analysis
2.7.4 Immunomedics Inc. Product and Services
2.7.5 Immunomedics Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.8 FuGENE
2.8.1 FuGENE Details
2.8.2 FuGENE Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 FuGENE SWOT Analysis
2.8.4 FuGENE Product and Services
2.8.5 FuGENE Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Immodulon-Therapeutics
2.10.1 Immodulon-Therapeutics Details
2.10.2 Immodulon-Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Immodulon-Therapeutics SWOT Analysis
2.10.4 Immodulon-Therapeutics Product and Services
2.10.5 Immodulon-Therapeutics Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Novartis SWOT Analysis
2.11.4 Novartis Product and Services
2.11.5 Novartis Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.12 BioMed Valley Discoveries Inc.
2.12.1 BioMed Valley Discoveries Inc. Details
2.12.2 BioMed Valley Discoveries Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 BioMed Valley Discoveries Inc. SWOT Analysis
2.12.4 BioMed Valley Discoveries Inc. Product and Services
2.12.5 BioMed Valley Discoveries Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.13 Juno Therapeutics Inc.
2.13.1 Juno Therapeutics Inc. Details
2.13.2 Juno Therapeutics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Juno Therapeutics Inc. SWOT Analysis
2.13.4 Juno Therapeutics Inc. Product and Services
2.13.5 Juno Therapeutics Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.14 UCL Business PLC.
2.14.1 UCL Business PLC. Details
2.14.2 UCL Business PLC. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 UCL Business PLC. SWOT Analysis
2.14.4 UCL Business PLC. Product and Services
2.14.5 UCL Business PLC. Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.15 Persimmune Inc.
2.15.1 Persimmune Inc. Details
2.15.2 Persimmune Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Persimmune Inc. SWOT Analysis
2.15.4 Persimmune Inc. Product and Services
2.15.5 Persimmune Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.16 Neurotech USA
2.16.1 Neurotech USA Details
2.16.2 Neurotech USA Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Neurotech USA SWOT Analysis
2.16.4 Neurotech USA Product and Services
2.16.5 Neurotech USA Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.17 Medlmmune Inc.
2.17.1 Medlmmune Inc. Details
2.17.2 Medlmmune Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Medlmmune Inc. SWOT Analysis
2.17.4 Medlmmune Inc. Product and Services
2.17.5 Medlmmune Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.18 Regeneron Pharmaceuticals Inc.
2.18.1 Regeneron Pharmaceuticals Inc. Details
2.18.2 Regeneron Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Regeneron Pharmaceuticals Inc. SWOT Analysis
2.18.4 Regeneron Pharmaceuticals Inc. Product and Services
2.18.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.19 Pluristem Therapeutics
2.19.1 Pluristem Therapeutics Details
2.19.2 Pluristem Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Pluristem Therapeutics SWOT Analysis
2.19.4 Pluristem Therapeutics Product and Services
2.19.5 Pluristem Therapeutics Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
2.20 NeoStem Oncology
2.20.1 NeoStem Oncology Details
2.20.2 NeoStem Oncology Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 NeoStem Oncology SWOT Analysis
2.20.4 NeoStem Oncology Product and Services
2.20.5 NeoStem Oncology Cell therapy Processing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cell therapy Processing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell therapy Processing Players Market Share
3.2.2 Top 10 Cell therapy Processing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cell therapy Processing Revenue and Market Share by Regions
4.2 North America Cell therapy Processing Revenue and Growth Rate (2015-2020)
4.3 Europe Cell therapy Processing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cell therapy Processing Revenue and Growth Rate (2015-2020)
4.5 South America Cell therapy Processing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cell therapy Processing Revenue and Growth Rate (2015-2020)
5 North America Cell therapy Processing Revenue by Countries
5.1 North America Cell therapy Processing Revenue by Countries (2015-2020)
5.2 USA Cell therapy Processing Revenue and Growth Rate (2015-2020)
5.3 Canada Cell therapy Processing Revenue and Growth Rate (2015-2020)
5.4 Mexico Cell therapy Processing Revenue and Growth Rate (2015-2020)
6 Europe Cell therapy Processing Revenue by Countries
6.1 Europe Cell therapy Processing Revenue by Countries (2015-2020)
6.2 Germany Cell therapy Processing Revenue and Growth Rate (2015-2020)
6.3 UK Cell therapy Processing Revenue and Growth Rate (2015-2020)
6.4 France Cell therapy Processing Revenue and Growth Rate (2015-2020)
6.5 Russia Cell therapy Processing Revenue and Growth Rate (2015-2020)
6.6 Italy Cell therapy Processing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cell therapy Processing Revenue by Countries
7.1 Asia-Pacific Cell therapy Processing Revenue by Countries (2015-2020)
7.2 China Cell therapy Processing Revenue and Growth Rate (2015-2020)
7.3 Japan Cell therapy Processing Revenue and Growth Rate (2015-2020)
7.4 Korea Cell therapy Processing Revenue and Growth Rate (2015-2020)
7.5 India Cell therapy Processing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cell therapy Processing Revenue and Growth Rate (2015-2020)
8 South America Cell therapy Processing Revenue by Countries
8.1 South America Cell therapy Processing Revenue by Countries (2015-2020)
8.2 Brazil Cell therapy Processing Revenue and Growth Rate (2015-2020)
8.3 Argentina Cell therapy Processing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cell therapy Processing by Countries
9.1 Middle East & Africa Cell therapy Processing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cell therapy Processing Revenue and Growth Rate (2015-2020)
9.3 UAE Cell therapy Processing Revenue and Growth Rate (2015-2020)
9.4 Egypt Cell therapy Processing Revenue and Growth Rate (2015-2020)
9.5 South Africa Cell therapy Processing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cell therapy Processing Revenue and Market Share by Type (2015-2020)
10.2 Global Cell therapy Processing Market Forecast by Type (2019-2024)
10.3 Products Revenue Growth Rate (2015-2025)
10.4 Services Revenue Growth Rate (2015-2025)
10.5 Software Revenue Growth Rate (2015-2025)
11 Global Cell therapy Processing Market Segment by Application
11.1 Global Cell therapy Processing Revenue Market Share by Application (2015-2020)
11.2 Cell therapy Processing Market Forecast by Application (2019-2024)
11.3 Cardiovascular Disease Revenue Growth (2015-2020)
11.4 Bone Repair Revenue Growth (2015-2020)
11.5 Neurological Disorders Revenue Growth (2015-2020)
11.6 Skeletal Muscle RepairImmune Diseases Revenue Growth (2015-2020)
12 Global Cell therapy Processing Market Size Forecast (2021-2025)
12.1 Global Cell therapy Processing Market Size Forecast (2021-2025)
12.2 Global Cell therapy Processing Market Forecast by Regions (2021-2025)
12.3 North America Cell therapy Processing Revenue Market Forecast (2021-2025)
12.4 Europe Cell therapy Processing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cell therapy Processing Revenue Market Forecast (2021-2025)
12.6 South America Cell therapy Processing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cell therapy Processing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cell therapy Processing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cell therapy Processing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cell therapy Processing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cell therapy Processing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Anthrogenesis Corp. Corporate Information, Location and Competitors
Table 6. Anthrogenesis Corp. Cell therapy Processing Major Business
Table 7. Anthrogenesis Corp. Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 8. Anthrogenesis Corp. SWOT Analysis
Table 9. Anthrogenesis Corp. Cell therapy Processing Product and Solutions
Table 10. Anthrogenesis Corp. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bluebird Bio Inc. Corporate Information, Location and Competitors
Table 12. Bluebird Bio Inc. Cell therapy Processing Major Business
Table 13. Bluebird Bio Inc. Cell therapy Processing Total Revenue (USD Million) (2018-2019)
Table 14. Bluebird Bio Inc. SWOT Analysis
Table 15. Bluebird Bio Inc. Cell therapy Processing Product and Solutions
Table 16. Bluebird Bio Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Epic Sciences Corporate Information, Location and Competitors
Table 18. Epic Sciences Cell therapy Processing Major Business
Table 19. Epic Sciences Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 20. Epic Sciences SWOT Analysis
Table 21. Epic Sciences Cell therapy Processing Product and Solutions
Table 22. Epic Sciences Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. BioNTech Corporate Information, Location and Competitors
Table 24. BioNTech Cell therapy Processing Major Business
Table 25. BioNTech Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 26. BioNTech SWOT Analysis
Table 27. BioNTech Cell therapy Processing Product and Solutions
Table 28. BioNTech Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. IBC Pharmaceuticals Inc. Corporate Information, Location and Competitors
Table 30. IBC Pharmaceuticals Inc. Cell therapy Processing Major Business
Table 31. IBC Pharmaceuticals Inc. Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 32. IBC Pharmaceuticals Inc. SWOT Analysis
Table 33. IBC Pharmaceuticals Inc. Cell therapy Processing Product and Solutions
Table 34. IBC Pharmaceuticals Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Cell Ideas Corporate Information, Location and Competitors
Table 36. Cell Ideas Cell therapy Processing Major Business
Table 37. Cell Ideas Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 38. Cell Ideas SWOT Analysis
Table 39. Cell Ideas Cell therapy Processing Product and Solutions
Table 40. Cell Ideas Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Immunomedics Inc. Corporate Information, Location and Competitors
Table 42. Immunomedics Inc. Cell therapy Processing Major Business
Table 43. Immunomedics Inc. Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 44. Immunomedics Inc. SWOT Analysis
Table 45. Immunomedics Inc. Cell therapy Processing Product and Solutions
Table 46. Immunomedics Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. FuGENE Corporate Information, Location and Competitors
Table 48. FuGENE Cell therapy Processing Major Business
Table 49. FuGENE Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 50. FuGENE SWOT Analysis
Table 51. FuGENE Cell therapy Processing Product and Solutions
Table 52. FuGENE Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Corporate Information, Location and Competitors
Table 54. Roche Cell therapy Processing Major Business
Table 55. Roche Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 56. Roche SWOT Analysis
Table 57. Roche Cell therapy Processing Product and Solutions
Table 58. Roche Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Immodulon-Therapeutics Corporate Information, Location and Competitors
Table 60. Immodulon-Therapeutics Cell therapy Processing Major Business
Table 61. Immodulon-Therapeutics Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 62. Immodulon-Therapeutics SWOT Analysis
Table 63. Immodulon-Therapeutics Cell therapy Processing Product and Solutions
Table 64. Immodulon-Therapeutics Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Novartis Corporate Information, Location and Competitors
Table 66. Novartis Cell therapy Processing Major Business
Table 67. Novartis Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 68. Novartis SWOT Analysis
Table 69. Novartis Cell therapy Processing Product and Solutions
Table 70. Novartis Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. BioMed Valley Discoveries Inc. Corporate Information, Location and Competitors
Table 72. BioMed Valley Discoveries Inc. Cell therapy Processing Major Business
Table 73. BioMed Valley Discoveries Inc. Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 74. BioMed Valley Discoveries Inc. SWOT Analysis
Table 75. BioMed Valley Discoveries Inc. Cell therapy Processing Product and Solutions
Table 76. BioMed Valley Discoveries Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Juno Therapeutics Inc. Corporate Information, Location and Competitors
Table 78. Juno Therapeutics Inc. Cell therapy Processing Major Business
Table 79. Juno Therapeutics Inc. Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 80. Juno Therapeutics Inc. SWOT Analysis
Table 81. Juno Therapeutics Inc. Cell therapy Processing Product and Solutions
Table 82. Juno Therapeutics Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. UCL Business PLC. Corporate Information, Location and Competitors
Table 84. UCL Business PLC. Cell therapy Processing Major Business
Table 85. UCL Business PLC. Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 86. UCL Business PLC. SWOT Analysis
Table 87. UCL Business PLC. Cell therapy Processing Product and Solutions
Table 88. UCL Business PLC. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Persimmune Inc. Corporate Information, Location and Competitors
Table 90. Persimmune Inc. Cell therapy Processing Major Business
Table 91. Persimmune Inc. Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 92. Persimmune Inc. SWOT Analysis
Table 93. Persimmune Inc. Cell therapy Processing Product and Solutions
Table 94. Persimmune Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Neurotech USA Corporate Information, Location and Competitors
Table 96. Neurotech USA Cell therapy Processing Major Business
Table 97. Neurotech USA Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 98. Neurotech USA SWOT Analysis
Table 99. Neurotech USA Cell therapy Processing Product and Solutions
Table 100. Neurotech USA Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Medlmmune Inc. Corporate Information, Location and Competitors
Table 102. Medlmmune Inc. Cell therapy Processing Major Business
Table 103. Medlmmune Inc. Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 104. Medlmmune Inc. SWOT Analysis
Table 105. Medlmmune Inc. Cell therapy Processing Product and Solutions
Table 106. Medlmmune Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Regeneron Pharmaceuticals Inc. Cell therapy Processing Type and Application
Table 108. Regeneron Pharmaceuticals Inc. Cell therapy Processing Major Business
Table 109. Regeneron Pharmaceuticals Inc. Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 110. Regeneron Pharmaceuticals Inc. SWOT Analysis
Table 111. Regeneron Pharmaceuticals Inc. Cell therapy Processing Product and Solutions
Table 112. Regeneron Pharmaceuticals Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Pluristem Therapeutics Corporate Information, Location and Competitors
Table 114. Pluristem Therapeutics Cell therapy Processing Major Business
Table 115. Pluristem Therapeutics Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 116. Pluristem Therapeutics SWOT Analysis
Table 117. Pluristem Therapeutics Cell therapy Processing Product and Solutions
Table 118. Pluristem Therapeutics Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. NeoStem Oncology Corporate Information, Location and Competitors
Table 120. NeoStem Oncology Cell therapy Processing Major Business
Table 121. NeoStem Oncology Cell therapy Processing Total Revenue (USD Million) (2017-2018)
Table 122. NeoStem Oncology SWOT Analysis
Table 123. NeoStem Oncology Cell therapy Processing Product and Solutions
Table 124. NeoStem Oncology Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Global Cell therapy Processing Revenue (Million USD) by Players (2015-2020)
Table 126. Global Cell therapy Processing Revenue Share by Players (2015-2020)
Table 127. Global Cell therapy Processing Revenue (Million USD) by Regions (2015-2020)
Table 128. Global Cell therapy Processing Revenue Market Share by Regions (2015-2020)
Table 129. North America Cell therapy Processing Revenue by Countries (2015-2020)
Table 130. North America Cell therapy Processing Revenue Market Share by Countries (2015-2020)
Table 131. Europe Cell therapy Processing Revenue (Million USD) by Countries (2015-2020)
Table 132. Asia-Pacific Cell therapy Processing Revenue (Million USD) by Countries (2015-2020)
Table 133. South America Cell therapy Processing Revenue by Countries (2015-2020)
Table 134. South America Cell therapy Processing Revenue Market Share by Countries (2015-2020)
Table 135. Middle East and Africa Cell therapy Processing Revenue (Million USD) by Countries (2015-2020)
Table 136. Middle East and Africa Cell therapy Processing Revenue Market Share by Countries (2015-2020)
Table 137. Global Cell therapy Processing Revenue (Million USD) by Type (2015-2020)
Table 138. Global Cell therapy Processing Revenue Share by Type (2015-2020)
Table 139. Global Cell therapy Processing Revenue Forecast by Type (2021-2025)
Table 140. Global Cell therapy Processing Revenue by Application (2015-2020)
Table 141. Global Cell therapy Processing Revenue Share by Application (2015-2020)
Table 142. Global Cell therapy Processing Revenue Forecast by Application (2021-2025)
Table 143. Global Cell therapy Processing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cell therapy Processing Picture
Figure 2. Global Cell therapy Processing Revenue Market Share by Type in 2019
Figure 3. Products Picture
Figure 4. Services Picture
Figure 5. Software Picture
Figure 6. Cell therapy Processing Revenue Market Share by Application in 2019
Figure 7. Cardiovascular Disease Picture
Figure 8. Bone Repair Picture
Figure 9. Neurological Disorders Picture
Figure 10. Skeletal Muscle RepairImmune Diseases Picture
Figure 11. Global Cell therapy Processing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Cell therapy Processing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Cell therapy Processing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Cell therapy Processing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Cell therapy Processing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Cell therapy Processing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Cell therapy Processing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Cell therapy Processing Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Cell therapy Processing Revenue Market Share in 2019
Figure 20. Global Top 10 Players Cell therapy Processing Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Cell therapy Processing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Cell therapy Processing Revenue Market Share by Regions (2015-2020)
Figure 24. Global Cell therapy Processing Revenue Market Share by Regions in 2018
Figure 25. North America Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 26. Europe Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 28. South America Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 30. North America Cell therapy Processing Revenue Market Share by Countries (2015-2020)
Figure 31. North America Cell therapy Processing Revenue Market Share by Countries in 2019
Figure 32. USA Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 33. Canada Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 35. Europe Cell therapy Processing Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Cell therapy Processing Revenue Market Share by Countries in 2019
Figure 37. Germany Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 38. UK Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 39. France Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 40. Russia Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 41. Italy Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Cell therapy Processing Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Cell therapy Processing Revenue Market Share by Countries in 2019
Figure 44. China Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 45. Japan Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 46. Korea Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 47. India Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 49. South America Cell therapy Processing Revenue Market Share by Countries (2015-2020)
Figure 50. South America Cell therapy Processing Revenue Market Share by Countries in 2019
Figure 51. Brazil Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Cell therapy Processing Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Cell therapy Processing Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 56. UAE Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Cell therapy Processing Revenue and Growth Rate (2015-2020)
Figure 59. Global Cell therapy Processing Revenue Share by Type (2015-2020)
Figure 60. Global Cell therapy Processing Revenue Share by Type in 2019
Figure 61. Global Cell therapy Processing Market Share Forecast by Type (2021-2025)
Figure 62. Global Products Revenue Growth Rate (2015-2020)
Figure 63. Global Services Revenue Growth Rate (2015-2020)
Figure 64. Global Software Revenue Growth Rate (2015-2020)
Figure 65. Global Cell therapy Processing Revenue Share by Application (2015-2020)
Figure 66. Global Cell therapy Processing Revenue Share by Application in 2019
Figure 67. Global Cell therapy Processing Market Share Forecast by Application (2021-2025)
Figure 68. Global Cardiovascular Disease Revenue Growth Rate (2015-2020)
Figure 69. Global Bone Repair Revenue Growth Rate (2015-2020)
Figure 70. Global Neurological Disorders Revenue Growth Rate (2015-2020)
Figure 71. Global Skeletal Muscle RepairImmune Diseases Revenue Growth Rate (2015-2020)
Figure 72. Global Cell therapy Processing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Cell therapy Processing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Cell therapy Processing Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Cell therapy Processing Revenue Market Forecast (2021-2025)
Figure 76. Europe Cell therapy Processing Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Cell therapy Processing Revenue Market Forecast (2021-2025)
Figure 78. South America Cell therapy Processing Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Cell therapy Processing Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
筋骨格障害幹細胞療法の世界市場 2020年 Market Overview The global Musculoskeletal Disorder Stem Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mu…- 細胞療法の世界市場 2020年 Market Overview The Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 幹細胞治療の世界市場 2020年 Market Overview The Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 細胞治療用細胞凍結培地の世界市場 2020年 Market Overview The global Cell Freezing Media for Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 13.1% in the forecast period of 2020 to 2025 and will expected to reach USD 95 million by 2025, from USD 58 million in 2019. The Cell F…
- 細胞移植療法の世界市場 2020年 Market Overview The Cell Transplantatio Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…